Kozielec Gregory F MD - Dallas, Texas 75204

Kozielec Gregory F MD is categorized under Doctors in Dallas, TX .

Business Name: Kozielec Gregory F MD
Contact Person: Gregory Kozielec
Address: 3414 Oak Grove Avenue, Dallas, Texas 75204
Phone Number: (214) 521-1153
Website Address: retinainstitute.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Casanova Mark A MD - Dallas, TX 75204
Burke Robert J MD - Dallas, TX 75204
Payne Paul B MD - Dallas, TX 75204
Littrell Christina P MD - Dallas, TX 75204
Crabtree Robert N MD - Dallas, TX 75204
Palmer David O MD - Dallas, TX 75204
Smith Philip O MD - Dallas, TX 75204
Smith Weldon L MD - Dallas, TX 75204
Hays Tracy D MD - Dallas, TX 75204
Therese Jasmine Dr Dc - Dallas, TX 75204
Elovitz Reuben MD - Dallas, TX 75204
Lartchenko Serge MD - Dallas, TX 75204
Gieser Steven MD - Dallas, TX 75204
Wiley Cherese M MD - Dallas, TX 75204
Rice Kim M MD - Dallas, TX 75204
Highbaugh D Michael MD - Dallas, TX 75204
Yeagley Susanne C MD - Dallas, TX 75204
Wilkerson Jennifer MD - Dallas, TX 75204
Mithani Aamir MD - Dallas, TX 75204
Gong Wei MD - Dallas, TX 75204

The company Kozielec Gregory F MD provides B2C services in the form of Doctors from its single location in Texas. 1 to 4 employees work for Kozielec Gregory F MD, and the business now earns $500.000 to $999.999 per annum.

Kozielec Gregory F MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Kozielec Gregory F MD, please call Gregory Kozielec with the phone number (214) 521-1153 or visit its single location at 3414 Oak Grove Avenue in Dallas, Texas 75204.

The location of the single location can also be found using the coordinates 32.80431,-96.79725. Read more details about this business on the webpage retinainstitute.com or follow the company’s social media accounts, on Twitter and on Facebook.